Capital increase in accordance with new Going Public Principles

Supplier of generics products, STADA Arzneimittel AG in Bad Vilbel, is planning a capital increase of between E250m and E350m. The planned capital increase is one of the first of its kind in accordance with the new German Going Public Principles. The Principles, which came into force on 1 September 2002, form a code of conduct for companies and issuing banks rendering advice on flotations. STADA intends to implement the capital increase by issuing up to approximately 6.8 million new shares both with and without subscription rights, in two tranches, under the direction of Deutsche Bank AG, which was advised by Baker & McKenzie.

Legal firm Ashurst Morris Crisp advised STADA on the public offering. The firm's Frankfurt capital markets team managed a cross-border team under the leadership of Reinhard Eyring and Hermann Schlindwein. Assisting were Dirk Janssen, Martina Rothe, Ann-Katrin Ponick, Eva Buchmann, Matthias Wiedenfels, Nina Goes, Jutta Geiger, Manja Epping, Kanchan Ketkar, Marcus Nothhelfer, Tobias Neufeld, Birgit Schöpfe, Ian Warner, Nick Plummer, Caroline Biles, Barbara Lievens, Carmen Perete, Jose Christian Bertram, Fiona Bohn, Stefano Roncoroni, Carlo Bruno, Milan partner Leonardo Proni, Isabelle Cheradame, Beatrice Bihr and Paris partner Guy Benda.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH